Other

Debt Securities, Amortized Cost Basis

Pfizer Debt Securities, Amortized Cost Basis decreased by 4.1% to $9.53B in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ4 2025
Last reportedQ1 2026
Metric ID: other_debt_securities_amortized_cost_basis

Historical Data

2 periods
 Q4 '25Q1 '26
Value$9.94B$9.53B
QoQ Change—-4.1%
Range$9.53B – $9.94B

Frequently Asked Questions

What is Pfizer's debt securities, amortized cost basis?
Pfizer (PFE) reported debt securities, amortized cost basis of $9.53B in Q1 2026.